112 results
Page 2 of 6
8-K
EX-1.1
92u9zx5l51g4kz2z nm
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
424B5
kmiml33j f3zbgns1xf
17 Feb 21
Prospectus supplement for primary offering
12:00am
424B5
7kfvt1g zjm1
11 Feb 21
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
0pypv1
20 Oct 20
Diffusion Pharmaceuticals Appoints Dr. Chris Galloway as Chief Medical Officer
5:30pm
424B2
cr8jeql0jqlekh
2 Oct 20
Prospectus for primary offering
4:16pm
8-K
EX-10.1
ldzxg
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-10.2
3p88i92l8 dl3wrk
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
424B5
o8wwutjv9r
19 May 20
Prospectus supplement for primary offering
5:29pm
8-K
EX-99.1
udfhqmjiynl
13 Jan 20
Diffusion Pharmaceuticals Appoints Life Sciences Veteran Dr. Robert Cobuzzi, Jr. to its Board of Directors
4:16pm
8-K
EX-10.1
nyl5lwrmfxhb6wass04
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-10.2
5b42mfuel4
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm